Search

Your search keyword '"Matsumoto, Shingo"' showing total 43 results

Search Constraints

Start Over You searched for: Author "Matsumoto, Shingo" Remove constraint Author: "Matsumoto, Shingo" Publisher springer science and business media llc Remove constraint Publisher: springer science and business media llc
43 results on '"Matsumoto, Shingo"'

Search Results

2. Utility of bronchoscopically obtained frozen cytology pellets for next-generation sequencing

3. Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population

4. Clinicopathological significance of peritumoral alveolar macrophages in patients with resected early-stage lung squamous cell carcinoma

8. Predictive value of lipoprotein(a) for assessing the prevalence and severity of lower-extremity peripheral artery disease among patients with acute coronary syndrome

9. Predictive value of neutrophil-to-lymphocyte ratio for the fatality of COVID-19 patients complicated with cardiovascular diseases and/or risk factors

12. The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

13. Glasgow prognostic score can be a prognostic indicator after percutaneous coronary intervention: a two-center study in Japan

15. Paired analysis of tumor mutation burden for lung adenocarcinoma and associated idiopathic pulmonary fibrosis

18. Morphological, immune and genetic features in biopsy sample associated with the efficacy of pembrolizumab in patients with non-squamous non-small cell lung cancer

22. Phase II, open-label, multicenter trial of crizotinib in Japanese patients with advanced non-small cell lung cancer harboring a MET gene alteration: Co-MET study

23. Proteasome inhibition disrupts the metabolism of fumarate hydratase- deficient tumors by downregulating p62 and c-Myc

25. Macrophage derived TNFα promotes hepatic reprogramming to Warburg-like metabolism

26. Association between skeletal muscle mass and serum concentrations of lipoprotein lipase, GPIHBP1, and hepatic triglyceride lipase in young Japanese men

27. A computational tool to detect DNA alterations tailored to formalin-fixed paraffin-embedded samples in cancer clinical sequencing

29. A secondary RET mutation in the activation loop conferring resistance to vandetanib

30. CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors

34. Association of variations in HLA class II and other loci with susceptibility to EGFR-mutated lung adenocarcinoma

35. Unique intravascular tumor microenvironment predicting recurrence of lung squamous cell carcinoma

36. Expression profiling of receptor tyrosine kinases in high-grade neuroendocrine carcinoma of the lung: a comparative analysis with adenocarcinoma and squamous cell carcinoma

38. Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302

39. Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung

40. Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy

41. Solid predominant histology predicts EGFR tyrosine kinase inhibitor response in patients with EGFR mutation-positive lung adenocarcinoma

Catalog

Books, media, physical & digital resources